Cegedim SD Rolls Out Longitudinal Patient Data in US

Healthcare market research company Cegedim Strategic Data (CSD) has rolled out its 'Longitudinal Patient Data' (LPD) to the US market.

CSD offers a range of market research services and solutions, and integrates primary and secondary analyses with its medical expertise to meet its customer's research needs.

The firm's new US patient database is drawn from electronic medical records and contains details of more than 28 million patients. Fully compliant with US and European privacy requirements, clients can potentially use the LPD data for analysis of drug treatment patterns; outcomes research; pharmacoeconomic studies; populating models; and health economic evaluations.

Bruno Lempernesse (pictured), CSD's COO and US Country Manager, comments: 'The Cegedim organization is very excited about this expansion since our clients have been asking for a reliable source of US LPD for many years. The new database offers a complete and consistent US and EU5 dataset for global research projects.'

Web site: www.cegedimstrategicdata.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Cegedim Strategic Data
• All news